Rhamnose modified bovine serum albumin as a carrier protein promotes the immune response against sTn antigen.
Journal
Chemical communications (Cambridge, England)
ISSN: 1364-548X
Titre abrégé: Chem Commun (Camb)
Pays: England
ID NLM: 9610838
Informations de publication
Date de publication:
21 Nov 2020
21 Nov 2020
Historique:
pubmed:
21
10
2020
medline:
20
5
2021
entrez:
20
10
2020
Statut:
ppublish
Résumé
Rhamnose and sTn antigen were co-conjugated to bovine serum albumin (BSA), a weakly immunogenic carrier protein, for cancer vaccine development. The immune responses against sTn have been significantly augmented with the involvement of Rha-specific antibodies to enhance antigen uptake.
Substances chimiques
Antigens, Tumor-Associated, Carbohydrate
0
sialosyl-Tn antigen
0
Serum Albumin, Bovine
27432CM55Q
Rhamnose
QN34XC755A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM